NCT06061341 - TruGraf Liver Gene Expression Serial Test | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2026

Conditions

Autoimmune Liver DiseaseAutoimmune HepatitisPrimary Sclerosing CholangitisPrimary Biliary Cirrhosis

Interventions

DIAGNOSTIC_TEST

TruGraf®

TruGraf® is a non-invasive blood-based test to assist the clinician in lowering immunosuppression in liver transplant patients. It is the first and only blood-based test that offers biomarker guidance to aid physicians in minimizing immunosuppression in transplant recipients.

Trial Locations (2)

63110

Washington University and Barnes Jewish Hospital, St Louis

Washington University School of Medicine, St Louis

All Listed Sponsors

collaborator

Transplant Genomics, Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER